The importance of adopting an informatics platform over point solutions
Large molecule R&D involves complex datasets, a broad range of sample types, and intricate cross-team collaboration. When it comes to streamlining these workflows using third-party informatics systems, there are two basic approaches: the point solution approach, and the platform approach.
In the more traditional point solution approach, R&D organizations work with a number of individual tools. With the platform approach, an organization purchases a suite of applications built on a common platform to satisfy the majority of the organization’s informatics needs.
In this article, we discuss why modern large molecule R&D requires a platform approach, and how point solutions fall short in supporting large molecule workflows.
From the bench to your inbox
Our monthly newsletter features science insights, industry best practices, and stories from teams pushing biotech forward.